What is ResMed's share buybacks?

ResMed (RMD) reported share buybacks of $175.01M in Q1 2026.

How has ResMed's share buybacks changed year-over-year?

ResMed's share buybacks increased by 133.3% year-over-year, from $75.03M to $175.01M.

What does share buybacks mean?

Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.

ResMed RMD Share Buybacks

Share Buybacks at other companies

Eli LillyLLY

$2.36B+96.3%

InogenINGN

$1.87M—

Inspire Medical SystemsINSP

$0-100%

Viemed Healthcare, Inc.VMD

$1.44M—

MedtronicMDT

$435M+58.8%

AbbottABT

$180M-35.7%

Other financials

Income statement

See full

Revenue$1.4B+10.8%

Gross profit$891.0M+16.3%

Operating income$499.8M+17.3%

Net income$398.7M+9.2%

EPS (diluted)$2.74+10.5%

Balance sheet

See full

Cash & equivalents$1.7B+78.0%

Total debt$1.1B+29.8%

Total equity$6.5B+17.1%

Total assets$8.8B+16.1%

Cash flow

See full

Operating cash flow$554.1M-4.2%

CapEx$33.7M+61.8%

Free cash flow$520.5M-6.7%

Valuation

See full

Market cap$28.27B-19.1%

Enterprise value$27.71B-19.8%

P/E18.6×-6.3×

P/S5.1×-1.7×

Profitability

See full

Gross margin61.6%+2.8pp

Operating margin34.2%+2.1pp

Net margin27.4%+1.3pp

FCF margin31.7%+0.4pp

Returns & leverage

See full

Return on equity25.2%-0.6pp

Debt / equity0.2×0.0×

Current ratio3×-0.4×

Where this comes from

Reported directly by ResMed in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The official record: ResMed’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about ResMed's share buybacks.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ResMed's share buybacks?: ResMed (RMD) reported share buybacks of $175.01M in Q1 2026.
How has ResMed's share buybacks changed year-over-year?: ResMed's share buybacks increased by 133.3% year-over-year, from $75.03M to $175.01M.
What does share buybacks mean?: Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.